Appili Therapeutics Inc. APLI.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.23M | -764.70K | -683.60K | -718.10K | -903.20K |
| Total Depreciation and Amortization | 1.00K | 900.00 | 0.00 | 2.40K | 2.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 324.90K | 334.80K | 192.40K | -73.00K | 124.50K |
| Change in Net Operating Assets | 875.30K | 216.30K | 290.50K | 237.40K | 771.40K |
| Cash from Operations | -26.70K | -212.70K | -200.70K | -551.30K | -4.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.50K | 2.60K | -600.00 | -30.10K | -29.30K |
| Issuance of Common Stock | -- | 100.00K | 177.50K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 175.00K | 18.80K | -27.40K | -47.30K | -13.00K |
| Cash from Financing | 123.20K | 88.50K | 107.20K | -56.20K | -30.60K |
| Foreign Exchange rate Adjustments | -25.20K | -1.60K | -4.00K | 43.90K | -39.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.30K | -125.90K | -97.50K | -563.70K | -74.60K |